Morgan Stanley Harrow Health, Inc. Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Harrow Health, Inc. stock. As of the latest transaction made, Morgan Stanley holds 365,015 shares of HROW stock, worth $15.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

365,015

Previous 222,850 63.79%

Holding current value

$15.1 Million

Previous $5.93 Million 88.07%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	BUY	$22.2 - $31.61 $3.16 Million - $4.49 Million	142,165 Added 63.79%	365,015 $11.1 Million
Q1 2025 May 15, 2025	BUY	$22.22 - $36.67 $458,398 - $756,502	20,630 Added 10.2%	222,850 $5.93 Million
Q4 2024 Feb 14, 2025	SELL	$33.39 - $57.5 $5.47 Million - $9.41 Million	-163,702 Reduced 44.74%	202,220 $6.78 Million
Q3 2024 May 14, 2025	BUY	$20.85 - $46.47 $6.11 Million - $13.6 Million	293,115 Added 402.59%	365,922 $16.5 Million
Q3 2024 Nov 14, 2024	BUY	$20.85 - $46.47 $6.11 Million - $13.6 Million	293,115 Added 402.59%	365,922 $16.5 Million
Q2 2024 May 14, 2025	SELL	$10.0 - $21.64 $1.29 Million - $2.8 Million	-129,413 Reduced 64.0%	72,807 $1.52 Million
Q2 2024 Oct 17, 2024	SELL	$10.0 - $21.64 $8.8 Million - $19 Million	-879,716 Reduced 92.36%	72,807 $1.52 Million
Q2 2024 Aug 14, 2024	SELL	$10.0 - $21.64 $8.8 Million - $19 Million	-879,716 Reduced 92.36%	72,807 $1.52 Million
Q1 2024 Oct 17, 2024	BUY	$9.3 - $13.23 $8.18 Million - $11.6 Million	879,716 Added 1208.28%	952,523 $12.6 Million
Q1 2024 Aug 16, 2024	SELL	$9.3 - $13.23 $3.85 Million - $5.48 Million	-414,218 Reduced 30.31%	952,523 $12.6 Million
Q1 2024 May 15, 2024	SELL	$9.3 - $13.23 $3.85 Million - $5.48 Million	-414,218 Reduced 30.31%	952,523 $12.6 Million
Q4 2023 Aug 16, 2024	BUY	$8.1 - $16.36 $10.5 Million - $21.2 Million	1,293,934 Added 1777.21%	1,366,741 $15.3 Million
Q4 2023 Feb 13, 2024	SELL	$8.1 - $16.36 $3.33 Million - $6.72 Million	-410,920 Reduced 23.12%	1,366,741 $15.3 Million
Q3 2023 Nov 15, 2023	BUY	$14.03 - $22.08 $117,346 - $184,677	8,364 Added 0.47%	1,777,661 $25.5 Million
Q2 2023 Aug 14, 2023	BUY	$17.37 - $28.08 $14.2 Million - $23 Million	818,467 Added 86.08%	1,769,297 $33.7 Million
Q1 2023 May 15, 2023	BUY	$13.84 - $21.46 $12.7 Million - $19.8 Million	920,669 Added 3052.51%	950,830 $20.1 Million
Q4 2022 Feb 14, 2023	BUY	$10.28 - $14.78 $188,792 - $271,434	18,365 Added 155.69%	30,161 $445,000
Q3 2022 Nov 14, 2022	SELL	$6.57 - $24.88 $82,289 - $311,622	-12,525 Reduced 51.5%	11,796 $142,000
Q2 2022 Oct 27, 2022	SELL	$5.75 - $7.74 $103,448 - $139,250	-17,991 Reduced 42.52%	24,321 $177,000
Q2 2022 Aug 15, 2022	SELL	$5.75 - $7.74 $103,448 - $139,250	-17,991 Reduced 42.52%	24,321 $177,000
Q1 2022 Oct 27, 2022	BUY	$6.77 - $8.66 $121,799 - $155,802	17,991 Added 73.97%	42,312 $289,000
Q1 2022 May 13, 2022	SELL	$6.77 - $8.66 $257,774 - $329,738	-38,076 Reduced 47.37%	42,312 $289,000
Q4 2021 Feb 14, 2022	SELL	$8.5 - $12.0 $39,125 - $55,236	-4,603 Reduced 5.42%	80,388 $695,000
Q3 2021 Nov 15, 2021	BUY	$6.99 - $10.6 $594,087 - $900,904	84,991 New	84,991 $773,000

Others Institutions Holding HROW

# of Institutions

181

Shares Held

21.5M

Call Options Held

390K

Put Options Held

413K

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $1.12B
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account